Fig. 1
From: GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
GTSE1 is highly expressed in OS and possibly correlates with unfavorable outcome. A expression profiling of GTSE1 in sarcoma in GEPIA; B, C expression of GTSE1 in OS tumor and para-tumorous tissues (n = 15) examined by RT-qPCR (B) and IHC staining (C), respectively (paired t test); D–E, expression of GTSE1 in OS cell lines (MNNG, MG-63, 143B, SaOS-2) and in normal hFOB 1.19 cells determined by RT-qPCR (D) and western blot analysis (E), respectively (one-way ANOVA vs. hFOB 1.19 cells); F, G overall survival (F) and disease-free survival (G) of patients with OS in the GEPIA database. Data were presented as the mean ± SD from three repetitions. *p < 0.05, **p < 0.01, ***p < 0.001